11
1
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T60011 |
HS220
|
MAPK | MAPK |
HS220 是 TAK1 抑制剂,TAK1 在炎症和细胞存活的信号通路中起关键作用。 | |||
T5190 |
GS-444217
GS 444217,GS444217 |
Apoptosis; ASK; MAPK | Apoptosis; MAPK |
GS-444217 是一种可口服的选择性 ATP 竞争性凋亡信号调节激酶 1 抑制剂,IC50为 2.87 nM。 | |||
T5643 |
NG25
|
MAPK | MAPK |
NG25 是TAK1(IC50:149 nM)和MAP4K2(IC50:21.7 nM)的双抑制剂。 | |||
T3101 |
NQDI-1
NQDI1,NQDI 1 |
Apoptosis; ASK; MAPK | Apoptosis; MAPK |
NQDI-1 (NQDI 1) 是一种凋亡信号调节激酶 1 抑制剂,Ki 为 500 nM,IC50为 3 μM。 | |||
T3350 |
Selonsertib
GS-4997 |
Apoptosis; ASK; MAPK | Apoptosis; MAPK |
Selonsertib (GS-4997) 是一种选择性的,具有生物口服可利用的凋亡信号调节激酶1 抑制剂,pIC50为 8.3。它具有潜在的抗炎、抗肿瘤和抗纤维化活性。 | |||
T13099 |
TC ASK 10
|
ASK; MAPK | Apoptosis; MAPK |
TC ASK 10 是选择性的,口服有效的细胞凋亡信号调节激酶 1 抑制剂,IC50为 14 nM。它对其他代表性激酶的抑制活性低于 50%,除 ASK2之外 (IC50为 0.51 μM)。 | |||
T3707 |
GNE-3511
GNE3511 |
DNA Alkylation; MAPK | DNA Damage/DNA Repair; MAPK |
GNE-3511是双亮氨酸拉链激酶 (DLK)抑制剂(Ki:0.5 nM)。 | |||
T9377 |
ASK1-IN-2
|
Apoptosis; ASK; MAPK | Apoptosis; MAPK |
ASK1-IN-2 是一种口服有活性的凋亡信号调节激酶 1 抑制剂(IC50:32.8 nM)。它可用于研究溃疡性结肠炎。 | |||
T4264 |
Takinib
EDHS-206 |
Apoptosis; MAPK | Apoptosis; MAPK |
Takinib (EDHS-206) 是一种TAK1自磷酸化的抑制剂,也是恶性疟原虫蛋白激酶 9 抑制剂,在 ATP 结合口袋内非竞争性结合。它诱导 TNF-α 刺激的细胞凋亡,可研究类风湿关节炎和转移性乳腺癌。 | |||
T16987 |
TAO Kinase inhibitor 1
|
Others; MAPK | MAPK; Others |
TAO Kinase inhibitor 1 是一种ATP 竞争性的thousand-and-one amino acid kinases (TAOK)选择性抑制剂,对于 TAOK1 和 TAOK2 的IC50s 分别为 11 nM 和 15 nM。它能够延迟有丝分裂以及诱导有丝分裂细胞死亡。 | |||
T69894 |
MAP3K14-IN-173
|
Others | Others |
MAP3K14-IN-173 is a potent MAP3K14 kinase inhibitor. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T14055 |
5Z-7-Oxozeaenol
FR148083,L783279,LL-Z 1640-2 |
VEGFR; FLT; MEK; MAPK; PDGFR; Antibiotic; Src | Angiogenesis; MAPK; Microbiology/Virology; Tyrosine Kinase/Adaptors |
5Z-7-Oxozeaenol (FR148083) 是一种天然抗原生动物抑制剂,不可逆的选择性抑制 TAK1和 VEGF-R2,IC50值分别为 8 nM 和 52 nM。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-04389 |
MAP3K8 Protein, Human, Recombinant (GST)
TPL2,MEKK8,EST,ESTF,COT,Tpl-2,c-COT,AURA2,mitogen-activated ... |
Human | Baculovirus Insect Cells |
Mitogen-activated protein kinase kinase kinase 8, also known as Cancer Osaka thyroid oncogene, Proto-oncogene c-Cot, Serine/threonine-protein kinase cot, Tumor progression locus 2 and MAP3K8, is a cytoplasm protein that belongs to the protein kinase superfamily, STE Ser/Thr protein kinase family and MAP kinase kinase kinase subfamily. MAP3K8 is expressed in several normal tissues and human tumor-derived cell lines. Isoform 1 of MAP3K8 is activated specifically during the S and G2/M phases of the... | |||
TMPH-01693 |
MAP3K14 Protein, Human, Recombinant (His & Myc)
MAP3K14,Serine/threonine-protein kinase NI... |
Human | E. coli |
Lymphotoxin beta-activated kinase which seems to be exclusively involved in the activation of NF-kappa-B and its transcriptional activity. Promotes proteolytic processing of NFKB2/P100, which leads to activation of NF-kappa-B via the non-canonical pathway. Could act in a receptor-selective manner. | |||
TMPY-05095 |
RAF1 Protein, Human, Recombinant (His & GST)
Raf-1 proto-oncogene, serine/threonine kinase,CRAF,NS5,CMD1N... |
Human | Baculovirus Insect Cells |
RAF1 gene is the cellular homolog of viral raf gene (v-raf). The encoded protein is a MAP kinase kinase kinase (MAP3K), which functions downstream of the Ras family of membrane associated GTPases to which it binds directly. Once activated, the cellular RAF1 protein can phosphorylate to activate the dual specificity protein kinases MEK1 and MEK2, which in turn phosphorylate to activate the serine/threonine specific protein kinases, ERK1 and ERK2. Activated ERKs are pleiotropic effectors of cell p... |